S2 Genomics, a leading innovator in tissue sample preparation systems, has unveiled its latest groundbreaking product, the Singulator™ 200+ System. This state-of-the-art technology represents a significant advancement in automated sample preparation specifically designed for single-cell formalin-fixed, paraffin-embedded (FFPE) tissues. By…
Transcat Inc. (NASDAQ:TRNS), a prominent provider of accredited calibration services and value-added rental/distribution of professional-grade handheld test, measurement, and control instrumentation, has declared that Mark Doheny will resign from his position as Chief Operating Officer, effective immediately. Mr. Doheny will…
Bayer and Google Cloud have joined forces to advance artificial intelligence (AI) solutions for supporting radiologists and enhancing patient care. Leveraging Google Cloud’s technology, including its generative AI (gen AI) tools, Bayer will enhance its innovation platform to expedite the…
SimBioSys®, an innovative TechBio firm harnessing spatial biophysics with artificial intelligence (AI) and computational modeling to revolutionize precision medicine in cancer, is thrilled to unveil its latest clinical offering, TumorSight Plan. This groundbreaking application is the first of its kind,…
HealthLock, a prominent solution in medical fraud and overbilling protection, has appointed two experienced executives to its leadership team: Adam Hewitt as Chief Revenue Officer (CRO) and David Putnam as Chief Growth Officer (CGO). In their roles, both leaders will…
Today, Q Bio Inc., a trailblazer in medical imaging technology, introduced Tensor Field Mapping (TFM), a cutting-edge advancement in Magnetic Resonance Imaging (MRI). TFM offers unprecedented insights into the human body, providing quantitative imaging data that surpasses the qualitative data…
Today, Gennao Bio, a private genetic medicine enterprise pioneering targeted nucleic acid therapies, revealed fresh preclinical findings regarding the use of its non-viral, cell-penetrating gene monoclonal antibody (GMAB) platform technology. These results showcase its potential as an antibody-drug conjugate (ADC)…
Today at the American Association for Cancer Research (AACR) 2024 Annual Meeting in San Diego, Genialis, a leading RNA-biomarker company, unveiled their latest AI/ML classifier, Genialis™ krasID. This innovative tool accurately predicts clinical benefit in patients treated with sotorasib, a…
Australian biotech firm, Ferronova, has commenced a clinical trial featuring their FerroTrace® nanoparticle technology in individuals diagnosed with gastric and esophageal cancers. This trial follows the successful completion of a first-in-human trial conducted between 2020 and 2022, focusing on oral…
Onchilles Pharma, a pioneering biotech firm specializing in cancer treatments harnessing a unique innate immune approach for targeted and potent tumor eradication, revealed groundbreaking preclinical findings today. The data pertained to N17465 administered systemically, presented orally, and N17350 directed at…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a prominent RNAi therapeutics firm, has unveiled encouraging outcomes from the KARDIA-2 Phase 2 trial. This study assessed the effectiveness and safety of a single subcutaneous dose of zilebesiran alongside one of three standard antihypertensive…
Edgewood Oncology, a biotech company specializing in BTX-A51 treatments for hematologic malignancies and solid tumors, has revealed fresh preclinical findings. The study, conducted by Dana-Farber Cancer Institute and Hebrew University-Hadassah Medical School, explores BTX-A51’s potential in human liposarcoma (LPS). These…